exp7711 has been researched along with l 162313 in 1 studies
| Studies (exp7711) | Trials (exp7711) | Recent Studies (post-2010) (exp7711) | Studies (l 162313) | Trials (l 162313) | Recent Studies (post-2010) (l 162313) |
|---|---|---|---|---|---|
| 18 | 0 | 1 | 31 | 0 | 10 |
| Protein | Taxonomy | exp7711 (IC50) | l 162313 (IC50) |
|---|---|---|---|
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0011 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0011 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0011 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldberg, MR; Greenlee, WJ; Irvin, JD; Prendergast, K; Smith, RD; Timmermans, PB; Wexler, RR | 1 |
1 review(s) available for exp7711 and l 162313
| Article | Year |
|---|---|
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Receptors, Angiotensin; Structure-Activity Relationship | 1996 |